Megakaryocyte- and Platelet-Derived Microparticles as Novel Diagnostic and Prognostic Biomarkers for Immune Thrombocytopenia
Altered cell-derived microparticles (MPs) have been reported in multiple autoimmune diseases. However, the roles of megakaryocyte- and platelet-derived MPs (MKMPs and PMPs) in immune thrombocytopenia (ITP) have not been investigated. In this study, we examined plasma MKMP and PMP levels in patients...
Main Authors: | Wen Wang, Bin Zuo, Yao Wang, Xinyu Li, Zhen Weng, Juping Zhai, Qingyu Wu, Yang He |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/22/6776 |
Similar Items
-
BLOOD PLATELETS AS ACTIVATORS AND REGULATORS OF INFLAMMATORY AND IMMUNE REACTIONS. PART 1. BASIC CHARACTERISTICS OF PLATELETS AS INFLAMMATORY CELLS
by: N. B. Serebryanaya, et al.
Published: (2018-12-01) -
Positive Association between Endothelium–Platelet Microparticles and Urinary Concentration of Lead and Cadmium in Adolescents and Young Adults
by: Chih-Kuo Lee, et al.
Published: (2021-08-01) -
Platelet Microparticle Controversial Role in Cancer
by: Mahnaz Nazari, et al.
Published: (2021-01-01) -
Platelet-Derived Microparticles and Autoimmune Diseases
by: Xiaoshuai Li, et al.
Published: (2023-06-01) -
A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
by: Gurleen Oberoi, et al.
Published: (2022-01-01)